TMEM128, also known as Transmembrane Protein 128, is a protein that in humans is encoded by the TMEM128 gene. TMEM128 has three variants, varying in 5' UTR's and start codon location.[1] TMEM128 contains four transmembrane domains and is localized in the Endoplasmic Reticulum membrane.[2][3][4] TMEM128 contains a variety of regulation at the gene, transcript, and protein level. While the function of TMEM128 is poorly understood, it interacts with several proteins associated with the cell cycle, signal transduction, and memory.

Gene

The TMEM128, or transmembrane protein 128, gene in humans is located on the minus strand at 4p16.3.[5] TMEM128 contains 5 exons total and is 12,701 base pairs long including introns.[1][5][6]

Transcripts

There are two isoforms of TMEM128.[7] Isoform 1 being the longest, consists of two variants differing in the 3' UTR region.[7] Variant 1 mRNA is 1,243 base pairs long while Variant 2 mRNA is 1,241 base pairs long.[1][8] Isoform 2 differs in the 5' UTR region of the protein and uses a different start codon location compared to the first variant.[7] This variant is longer at 1,785 base pairs and has a different N-terminus.[9]

Neighboring genes

TMEM128 is neighbored upstream by LYAR, Ly1 antibody reactive, and downstream by OTOP1, Otopetrin 1.[10]

Protein

Isoform 1

TMEM128 Isoform 1 translates into a protein of 165 amino acids long, containing four transmembrane domains.[2] These domains exist at amino acids 49–69, 81–101, 119–139, and 144–164.[2] Isoform 1 is18,882 Da and has a pI of 6.27.[11] Using compositional analysis, the amino acid composition is similar to the average protein and there are no significant repeats in the protein.[11]

Isoform 2

Isoform 2 translates into a protein of 141 amino acids long, also containing four transmembrane domains.[12][13] Isoform 2 has a different molecular weight and isoelectric point compared to Isoform 1, coming in at 16,093 Da and having a pI of 6.8.[11]

Secondary structure

Secondary structure composition
Type of secondary structureNumber of amino acidsPercent composition
Alpha helix3420.61%
Extended strand5935.76%
Random coil7243.64%

Predicted secondary structure composition shows that most of the secondary structure consists of random coils.[14] No disulfide bonds are predicted to be present.[15]

Membrane topology of TMEM128 shows the four transmembrane domains, longer N-terminus, and shorter C terminus.

Tertiary structure

Tertiary structure is predicted to have four spiral domains in TMEM128. These domains are the transmembrane sections of the protein. For the above models, it is colored rainbow from N-terminus to C-terminus.

Regulation of expression

Gene level regulation

Several promotors/enhancers of TMEM128 exist, with the GH04J00427 promotor located near the start of transcription, the GH04J004540 enhancer located downstream, and GH04J004264 enhancer located upstream of their target gene.[5][10] TMEM128 sequence also contains many binding sites for various transcription factors, including TATA box, CCAAT binding protein, and cAMP-responsive element binding protein.[16]

Expression of TMEM128 is also regulated at the gene level through differential tissue expression as seen with the image to the left. Red bars represent absolute expression while blue dots represent relative expression. TMEM128 is expressed highly in areas such as the adrenal gland and spinal cord, while is lower in areas such as the liver and bone marrow.[7]

Transcript level regulation

Several miRNAs have binding sites on the 3' UTR of TMEM128 including:[17]

  • has-miR-300
  • has-miR-188-5p
  • has-miR-506-3p
  • has-miR-3163
  • has-miR-548t-5p
  • has-miR-3163
  • has-miR-548t-5p
  • has-miR-548az-5p

These miRNAs can participate in RNA silencing to prevent the expression of the mRNA.

Analyses of mouse brains show lack of region-specific expression throughout.[18]

Protein level regulation

In terms of protein regulation, TMEM128 contains many different post-translational domains including glycation,[19] phosphorylation,[20] SUMOylation,[21] and O-GlcNAc[22] as seen below:

ModificationAmino acid number
Phosphorylation3, 4, 52, 124, 135, 162
Glycation70, 73, 115
Nuclear export signal[23]88-95
SUMOylation39-42, 115–118, 161–165
O-GlcNAc3, 4, 34, 35, 123
Acetylation[24]40, 41, 43, 73

Post-translational modification alters protein structure and can thus alter protein function and viability.

Sub-cellular localization

TMEM128 was found to be located in the Endoplasmic Reticulum membrane, with the N-terminus and C-terminus facing into the cytoplasm.[3][4]

Evolution

Paralogs

There are no known paralogs of TMEM128.[25]

Orthologs

Orthologs of TMEM128 have not been found outside of Eukaryotes.[25] Inside of Eukaryotes, TMEM128 orthologs have been found in mammals, birds, and several fungi. Mammals contained the highest amount of conservation at no less than 71% conservation. The most distant ortholog detected was the Diversispora epigaea, a fungus. The transmembrane domains of this protein remain the most conserved throughout species, with key amino acids Trp51, Trp139, and Trp142 being conserved in all species with orthologous proteins. All information below was obtained through NCBI BLAST.[25]

Orthologs of TMEM128
Genus and speciesCommon nameDate of Divergence (MYA)[26]Accession numberSequence lengthSequence identity
Homo sapiensHuman0NP_001284480.1165100%
Rhinopithecus roxellanaGolden snub-nosed monkey28.81XP_010355887.216597%
Mus musculusHouse mouse89NP_001343889.116381%
Microtus ochrogasterPrairie vole89XP_00536602116480%
Ovis ariesSheep94XP_014952114.216583%
Vulpes vulpesRed fox94XP_025854088.116582%
Pteropus vampyrusLarge flying fox94XP_011372965.116581%
Orcinus orcaKiller whale94XP_004269680.116581%
Monodelphis domesticaGray short-tailed opossum160XP_001371407.317071%
Taeniopygia guttataZebra finch318XP_002193492.317368%
Alligator sinensisChinese alligator318XP_006016834.117267%
Pogona vitticepsCentral bearded dragon318XP_020633929.116362%
Xenopus laevisAfrican clawed frog351.7NP_001084889.116652%
Orbicella faveolataMountainous star coral687XP_020610022.117138%
Exaiptasia pallidaSea anenmone687XP_028518835.116936%
Octopus vulgarisCommon octopus736XP_029645279.118433%
Brachionus plicatilisN/A736RNA25638.117028%
Crassostrea virginicaEastern oyster736XP_022343076.120028%
Diversispora epigaeaN/A1017RHZ70611.117624%

Mutation rate

The evolution rate is at a medium pace, slower than the fibrinogen alpha chain but faster than cytochrome c, suggesting neither positive or negative selection at this locus.

Interacting proteins

TMEM128 has been found via yeast two-hybrid assays to interact with:

  • Arc/Arg 3.1, also known as Activity-regulated cytoskeleton-associated protein, which helps facilitate learning and memory processes[3]
  • GRB2, also known as Growth factor receptor-bound protein 2, which is involved in cell development and signal transduction.[27]
  • BCL2L13, also known as B-cell lymphoma 2-like 13, which is an apoptosis facilitator[28]
  • CLN8, also known as Ceroid-lipofuscinosis neuronal 8, which acts as a receptor in the Golgi and Endoplasmic Reticulum.[29]
  • RABAC1, also known as Prenylated Rab acceptor 1, which assists in vesicle transport.[30]
  • TMPRSS2, also known as Transmembrane protease, serine 2, which has a poorly understood function.[31]
  • GJB5, also known as Gap junction beta-5 protein or connexin-31.1, which functions as a gap junction.[31]

Function

The biological function of TMEM128 is still poorly understood. As this is a transmembrane protein, common functions may include receptors, channels, or anchorage.[32] Because TMEM128 has post-translational modification sites, alternative protein states may be present that permit TMEM128 to have different forms. For example, phosphorylation of TMEM128 may make it bind to different substrates through conformational change.[33] TMEM128 also has a variety of interactions with other proteins as discussed above, suggesting it may have a broad range of action.

Clinical significance

Cancer

TMEM128 has been found to show moderate to strong positivity in some patients with carcinoma, with other types of cancer such as melanoma, glioma, breast, ovarian, renal, and pancreatic showing weak to moderate positivity.[34] TMEM128 also has been found to show low cancer specificity.[34]

Skeletal muscle

TMEM128 expression is experimentally associated with presence of the ROR alpha1 protein, as TMEM128 was found in lower quantities when ROR alpha1 was deleted.[35][36]

Skin

TMEM128 expression was lowered following a null mutation of TAp63 in skin cells.[37][38]

Cardiac muscle

TMEM128 expression was increased following a Trypanosoma cruzi infection.[39][40]

Neurological diseases

While it has been associated with several diseases such as Wolf-Hirschhorn Syndrome, no evidence exists for the exact cause of this syndrome and may only be correlation because of location on chromosome 4[5][41]

Mutations

Several SNPs have been found in association with TMEM128:[42]

Key SNPs of TMEM128
mRNA positionAmino acid positiondbSNP rs#Reference alleleSNP alleleFunction
16943rs771177507ACMissense
18649rs146625911ACMissense
20455rs1434953873GTMissense
27077rs13135886AGMissense
463139rs757745482TCMissense
466142rs1213450146GANonsense
512158rs202215273GA, TMissense

References

  1. ^ "Transmembrane Protein 128, transcript variant 1, mRNA". NCBI. March 1, 2020.
  2. ^ "transmembrane protein 128 isoform 1 [Homo sapiens] - Protein - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2020-04-29.
  3. ^ Gutzmann, Jakob (2013). "Characterization of Tmem128 – An activity regulated ER protein, interacting with the immediate early gene Arc/Arg3.1". Refubium. doi:10.17169/refubium-14701
  4. ^ "PSORT II Prediction". psort.hgc.jp. Retrieved 2020-05-01.
  5. ^ "TMEM128 Gene - GeneCards | TM128 Protein | TM128 Antibody". www.genecards.org. Retrieved 2020-02-07.
  6. ^ "Homo sapiens chromosome 4, GRCh38.p13 Primary Assembly". 2020-03-02.
  7. ^ "TMEM128 transmembrane protein 128 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2020-04-29.
  8. ^ "Homo sapiens transmembrane protein 128 (TMEM128), transcript variant 2, mRNA". 2019-05-31.
  9. ^ "Homo sapiens transmembrane protein 128 (TMEM128), transcript variant 3, mRNA". 2019-08-03.
  10. ^ "Human hg38 chr4:4,235,542-4,248,223 UCSC Genome Browser v397". genome.ucsc.edu. Retrieved 2020-04-30.
  11. ^ "SAPS < Sequence Statistics < EMBL-EBI". www.ebi.ac.uk. Retrieved 2020-04-29.
  12. ^ "Phobius". phobius.sbc.su.se. Retrieved 2020-04-29.
  13. ^ "transmembrane protein 128 isoform 2 [Homo sapiens] - Protein - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2020-04-29.
  14. ^ "NPS@ : GOR4 secondary structure prediction". npsa-prabi.ibcp.fr. Retrieved 2020-05-02.
  15. ^ "DISULFIND - Cysteines Disulfide Bonding State and Connectivity Predictor". disulfind.dsi.unifi.it. Retrieved 2020-04-30.
  16. ^ "Transcription factor binding sites for GXP_149843"
  17. ^ "miRDB - MicroRNA Target Prediction Database". www.mirdb.org. Retrieved 2020-05-02.
  18. ^ "Experiment Detail :: Allen Brain Atlas: Mouse Brain". mouse.brain-map.org. Retrieved 2020-05-03.
  19. ^ "NetGlycate 1.0 server predication of glycation"
  20. ^ "Kinase binding site prediction for TMEM128". The CUCKOO Workgroup
  21. ^ "SUMOplot Analysis Program Results for TMEM128"
  22. ^ "YinOYand 1.2 prediction of O-GlcNAc sites for TMEM128"
  23. ^ "NetNES 1.1 Server". www.cbs.dtu.dk. Retrieved 2020-05-01.
  24. ^ ":::PAIL - Prediction of Acetylation on Internal Lysines:::". bdmpail.biocuckoo.org. Archived from the original on February 24, 2020. Retrieved 2020-05-03.
  25. ^ "BLAST: Basic Local Alignment Search Tool". blast.ncbi.nlm.nih.gov. Retrieved 2020-04-30.
  26. ^ "TimeTree :: The Timescale of Life". www.timetree.org. Retrieved 2020-05-02.
  27. ^ Grossmann A, Benlasfer N, Birth P, Hegele A, Wachsmuth F, Apelt L, Stelzl U (March 2015). "Phospho-tyrosine dependent protein-protein interaction network". Molecular Systems Biology. 11 (3): 794. doi:10.15252/msb.20145968. PMC 4380928. PMID 25814554
  28. ^ Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, Kamburov A, Ghiassian SD, Yang X, Ghamsari L, Balcha D, Begg BE, Braun P, Brehme M, Broly MP, Carvunis AR, Convery-Zupan D, Corominas R, Coulombe-Huntington J, Dann E, Dreze M, Dricot A, Fan C, Franzosa E, Gebreab F, Gutierrez BJ, Hardy MF, Jin M, Kang S, Kiros R, Lin GN, Luck K, MacWilliams A, Menche J, Murray RR, Palagi A, Poulin MM, Rambout X, Rasla J, Reichert P, Romero V, Ruyssinck E, Sahalie JM, Scholz A, Shah AA, Sharma A, Shen Y, Spirohn K, Tam S, Tejeda AO, Trigg SA, Twizere JC, Vega K, Walsh J, Cusick ME, Xia Y, Barabási AL, Iakoucheva LM, Aloy P, De Las Rivas J, Tavernier J, Calderwood MA, Hill DE, Hao T, Roth FP, Vidal M (November 2014). "A proteome-scale map of the human interactome network". Cell. 159 (5): 1212–1226. doi:10.1016/j.cell.2014.10.050. PMC 4266588. PMID 25416956
  29. ^ Passantino R, Cascio C, Deidda I, Galizzi G, Russo D, Spedale G, Guarneri P (March 2013). "Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833 (3): 529–40. doi:10.1016/j.bbamcr.2012.10.030. PMID 23142642
  30. ^ Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW (May 2017). "Architecture of the human interactome defines protein communities and disease networks". Nature. 545 (7655): 505–509. Bibcode:2017Natur.545..505H. doi:10.1038/nature22366. PMC 5531611. PMID 28514442
  31. ^ Luck K, Kim DK, Lambourne L, Spirohn K, Begg BE, Bian W, Brignall R, Cafarelli T, Campos-Laborie FJ, Charloteaux B, Choi D, Coté AG, Daley M, Deimling S, Desbuleux A, Dricot A, Gebbia M, Hardy MF, Kishore N, Knapp JJ, Kovács IA, Lemmens I, Mee MW, Mellor JC, Pollis C, Pons C, Richardson AD, Schlabach S, Teeking B, Yadav A, Babor M, Balcha D, Basha O, Bowman-Colin C, Chin SF, Choi SG, Colabella C, Coppin G, D'Amata C, De Ridder D, De Rouck S, Duran-Frigola M, Ennajdaoui H, Goebels F, Goehring L, Gopal A, Haddad G, Hatchi E, Helmy M, Jacob Y, Kassa Y, Landini S, Li R, van Lieshout N, MacWilliams A, Markey D, Paulson JN, Rangarajan S, Rasla J, Rayhan A, Rolland T, San-Miguel A, Shen Y, Sheykhkarimli D, Sheynkman GM, Simonovsky E, Taşan M, Tejeda A, Tropepe V, Twizere JC, Wang Y, Weatheritt RJ, Weile J, Xia Y, Yang X, Yeger-Lotem E, Zhong Q, Aloy P, Bader GD, De Las Rivas J, Gaudet S, Hao T, Rak J, Tavernier J, Hill DE, Vidal M, Roth FP, Calderwood MA (April 2020). "A reference map of the human binary protein interactome". Nature. 580 (7803): 402–408. Bibcode:2020Natur.580..402L. doi:10.1038/s41586-020-2188-x. PMC 7169983. PMID 32296183
  32. ^ "Membrane Proteins | BioNinja". ib.bioninja.com.au. Archived from the original on March 25, 2020. Retrieved 2020-02-07.
  33. ^ "Phosphorylation - US". www.thermofisher.com. Retrieved 2020-05-02.
  34. ^ "Expression of TMEM128 in cancer - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2020-05-02.
  35. ^ "GDS3720 / ILMN_1248235". www.ncbi.nlm.nih.gov. Retrieved 2020-05-02.
  36. ^ Raichur S, Fitzsimmons RL, Myers SA, Pearen MA, Lau P, Eriksson N, Wang SM, Muscat GE (July 2010). "Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle". Nucleic Acids Research. 38 (13): 4296–312. doi:10.1093/nar/gkq180. PMC 2910057. PMID 20338882
  37. ^ "GDS1435 / 107124_at". www.ncbi.nlm.nih.gov. Retrieved 2020-05-02.
  38. ^ Koster MI, Kim S, Huang J, Williams T, Roop DR (January 2006). "TAp63alpha induces AP-2gamma as an early event in epidermal morphogenesis". Developmental Biology. 289 (1): 253–61. doi:10.1016/j.ydbio.2005.10.041. PMID 16324689
  39. ^ "GDS5112 / 1448317_at". www.ncbi.nlm.nih.gov. Retrieved 2020-05-02.
  40. ^ Silva GK, Costa RS, Silveira TN, Caetano BC, Horta CV, Gutierrez FR, Guedes PM, Andrade WA, De Niz M, Gazzinelli RT, Zamboni DS, Silva JS (September 2013). "Apoptosis-associated speck-like protein containing a caspase recruitment domain inflammasomes mediate IL-1β response and host resistance to Trypanosoma cruzi infection". Journal of Immunology. 191 (6): 3373–83. doi:10.4049/jimmunol.1203293. PMID 23966627. S2CID 25181644
  41. ^ Yang WX, Pan H, Li L, Wu HR, Wang ST, Bao XH, Jiang YW, Qi Y (March 2016). "Analyses of Genotypes and Phenotypes of Ten Chinese Patients with Wolf-Hirschhorn Syndrome by Multiplex Ligation-dependent Probe Amplification and Array Comparative Genomic Hybridization". Chinese Medical Journal. 129 (6): 672–8. doi:10.4103/0366-6999.177996. PMC 4804413. PMID 26960370
  42. ^ [https://www.ncbi.nlm.nih.gov/variation/view/?q=85013[geneid "SNP linked to Gene (geneID:85013) Via Contig Annotation"]. www.ncbi.nlm.nih.gov. Retrieved 2020-05-02.